Chemical Factory Closed in South West France After Toxic Waste Outcry
French pharmaceuticals group Sanofi announced late Monday an immediate halt in production at a chemical factory in southwest France, in the wake of media reports that toxic waste emissions exceeded the norms.
"Sanofi Chemical has decided from today to stop production at its Mourenx site and to carry out the announced technical improvements needed to return to normal," the group said in a brief statement.
It added that it was conducting an internal inquiry "to better understand the causes and history of the situation."
Earlier Monday, Sanofi had admitted there was "a problem of exceeding the threshold for the vapour waste of solvents," but it insisted that the local population was not exposed to levels higher than those laid down by regulation, a finding it said was determined by an independent health impact study.
The Mourenx factory with around 50 employees has been at the heart of an environmental outcry since Sunday.
France Nature Environment (FNE) said in a statement that the site has been emitting "dangerous material at astronomical levels".
FNE, a federation of some 3,500 environmental associations, claims that in reality the factory's emissions are "7,000 times more than the authorised
norm... sending astronomical quantities of pollutants into the air".
FNE and a local group Sepanso 64 had demanded the immediate shutdown of the factory, noting in particular that the chemical compound bromopropane in the emissions can hurt fertility or the foetus, and also irritate a person's respiratory system and the skin.
Sanofi meanwhile said that it has already instituted an action plan to collect and treat the waste to significantly reduce it and that it had planned
10 days ago to carry out summer maintenance of the site.
2026-10-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
U.S.-Iran Détente Triggers Oil Price Plunge, Energy and Chemical Sectors Tumble
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
"Zipper-Like" Opening and Closing of Hormuz Coupled with Russian Export Ban Send Energy and Chemical Prices Soaring
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
AUTOMA Chem 2026: Powering Industry 4.0 in Chemistry
-
Chemical Raw Materials: How to Source Quality Suppliers & Understand Grades
-
Big adjustment! Basf quietly closed 11 factories in Germany and transferred to China for plant investment!
-
Fluorine chemical: profit generally declined, under the pressure to expand profit space
Recommend Reading
-
“Deregulation” or “Concession”? The Hidden Crisis Behind India’s Repeal of QCOs on Seven Key Petrochemicals
-
MDI Price Surge Hits EMEAI: Is This a Market Correction or the Beginning of a Supply Crisis?
-
Hormuz Disruptions Affect Nearly 20% of Global Ethylene Capacity as Polyethylene Supply Tightens
-
Sekisui Specialty Chemicals Has Announced a Global Price Increase
-
Two Commercial Ships Confirmed Sunk Near Strait of Hormuz Within 24 Hours
-
September Maleic Anhydride Prices in China Continue to Rise
-
Business Society October 16, 2026 ABS Market Outlook: Volatility
-
Business Society September 30, 2026 Maleic Anhydride Trend Analysis: Volatility
-
Business Society October 16, 2026 Acrylonitrile Trend Analysis: Strong Consolidation
-
September China urea market trend fluctuates and rises